ATXS: Astria Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Biomolekulalarni tezlashtirilgan skrining qilish uchun robotlashtirilgan laboratoriyalarning joriy etilishi Astria Therapeutics (ATXS) uchun dori vositalarini kashf qilishni optimallashtiradi. Tarixiy PEG koeffitsiyenti dinamikasi ushbu avtomatlashtirish natijalarini vizuallashtiradi, bunda 0.00 ko'rsatkichi metrikaning holatini ifodalaydi. Shaffof boshqaruv moliyaviy intizomni saqlagan holda, asosiy STAR-0215 loyihasini samarali rivojlantirmoqda. Shu bilan birga, angioedemaga qarshi uzoq muddatli ta'sir qiluvchi dori vositasining yaratilishi kompaniyaga terapevtik qulaylik borasida sezilarli ustunlik beradi.
Astria Therapeutics (ATXS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Astria Therapeutics|ATXS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi astriatx.com|ATXS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Astria Pharma|ATXS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Astria Therapeutics|Oraliq qoplama koeffitsiyenti astriatx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ATXS - Sof daromad|Kelajakdagi sof foyda Astria Therapeutics|ATXS - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Astria Corp|ATXS - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Astria Pharma|ATXS - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Astria Therapeutics|ATXS - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi astriatx.com|ATXS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Astria Therapeutics
Kompaniyaning umumiy tahlili:ATXS - Astria Therapeutics Inc
Aktivning operatsion kuchini baholash foydalanilayotgan daromadlarining bozor qiymatini ularning o'sish sur'ati bilan solishtirishni talab qiladi, bunda birdan past bo'lgan PEG ko'rsatkichi biznesning fundamental jihatdan past baholanganligidan dalolat beradi. Astria Therapeutics (ATXS) uchun ushbu filtr juda muhimdir, chunki u investorlarga klinik sinovlar xavflari va IPO dan keyingi kapital yetarliligi sharoitida spekulyativ pasayishlarni haqiqiy o'sishdan ajratish imkonini beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|TRML - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori PGEN|PHAR (Pharming Group NV) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunome.com (IMNM)|Gossamer Bio - PEG multiplikatori|KALV - PEG multiplikatori|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori SVRA|RIGL (rigel.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori ANAB|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. (JBIO) - O‘sish sur’atiga tuzatilgan narx-foyda|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KYTX (kyvernatx.com)|TLSA: PEG multiplikatori|Cabaletta Bio Inc. (CABA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|Theratechnologies, Inc - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AVTX|ELDN - O‘sish sur’atiga tuzatilgan narx-foyda|Agenus Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Climb Bio Inc. CLYM|ZURA: Narx-foyda va o‘sish multiplikatori|aTyr Pharmaceuticals - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ADAG: PEG multiplikatori|IMA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|STTK (Shattuck Labs Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Equillium Bio (EQ)|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|XFOR: Narx-foyda va o‘sish multiplikatori|Adicet Bio - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CELU (celularity.com) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti INMB|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|kezarlifesciences.com (KZR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGM Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|OCEA: PEG multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
